Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $13 price target.
Olaplex Shares Move Lower On Volume Following Short Report From The Bear Cave Titled ‘Problems at Olaplex Holdings (OLPX)’
https://thebearcave.substack.com/p/problems-at-olaplex-holdings-olpx